Drug profile · INN
selexipag
UPTRAVI
- US status
- approved
- Patents linked
- 1
- News articles
- 0
Quick answer
selexipag (UPTRAVI) is an FDA-listed pharmaceutical active ingredient. Route of administration: oral. Current US regulatory status: approved.
Key facts
INN selexipag
Brand UPTRAVI
Route ORAL
Formulation POWDER
ATC code B01AC27
Related patents
Search patents →Frequently asked questions
What is selexipag?
selexipag (UPTRAVI) is an FDA-listed pharmaceutical active ingredient. Route of administration: oral. Current US regulatory status: approved.
What is the brand name for selexipag?
UPTRAVI is a marketed brand name for selexipag. Check FDA Drugs@FDA for the current US label holder and prescribing information.
What is the US approval status of selexipag?
selexipag has approved status in the United States according to our Drugs@FDA-derived records. Verify on the official FDA label before clinical or commercial decisions.